These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18655368)

  • 41. β-Catenin and E-cadherin expression in stage I adult-type granulosa cell tumour of the ovary: correlation with tumour morphology and clinical outcome.
    Stewart CJ; Doherty D; Guppy R; Louwen K; Leung YC
    Histopathology; 2013 Jan; 62(2):257-66. PubMed ID: 22958082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
    Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
    J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas.
    El-Bahrawy MA; Rowan A; Horncastle D; Tomlinson I; Theis BA; Russell RC; Stamp G
    Am J Surg Pathol; 2008 Jan; 32(1):1-7. PubMed ID: 18162763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
    Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
    Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beta-catenin and E-cadherin expression in salivary gland tumors.
    Furuse C; Cury PR; Altemani A; dos Santos Pinto D; de Araújo NS; de Araújo VC
    Int J Surg Pathol; 2006 Jul; 14(3):212-7. PubMed ID: 16959701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
    Saha B; Arase A; Imam SS; Tsao-Wei D; Naritoku WY; Groshen S; Jones LW; Imam SA
    Prostate; 2008 Jan; 68(1):78-84. PubMed ID: 18008331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. E-cadherin as a prognostic marker in human serous carcinomas of the ovary: an immunohistochemical analysis.
    Dian D; Brüning A; Mylonas I
    Arch Gynecol Obstet; 2011 Aug; 284(2):437-43. PubMed ID: 20803206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma.
    Turunen M; Talvensaari-Mattila A; Soini Y; Santala M
    Anticancer Res; 2009 Dec; 29(12):5185-9. PubMed ID: 20044634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of WNT-1 on beta-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma.
    Zhang WM; Lo Muzio L; Rubini C; Yan G
    Oncol Rep; 2005 Jun; 13(6):1095-9. PubMed ID: 15870927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
    Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H
    Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis.
    Ryabtseva OD; Lukianova NY; Shmurakov YA; Polishchuk LZ; Antipova SV
    Exp Oncol; 2013 Sep; 35(3):211-8. PubMed ID: 24084461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in immunoexpression of E-cadherin and beta-catenin in oral squamous cell carcinoma with and without nodal metastasis.
    Lopes FF; da Costa Miguel MC; Pereira AL; da Cruz MC; de Almeida Freitas R; Pinto LP; de Souza LB
    Ann Diagn Pathol; 2009 Feb; 13(1):22-9. PubMed ID: 19118778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
    Wen YH; Yee H; Goswami S; Shukla PS
    Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis.
    Mahomed F; Altini M; Meer S
    Oral Dis; 2007 Jul; 13(4):386-92. PubMed ID: 17577324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered expression of β-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma.
    Bhagat R; Premalata CS; Shilpa V; Pallavi VR; Ramesh G; Vijay CR; Krishnamoorthy L
    Tumour Biol; 2013 Aug; 34(4):2459-68. PubMed ID: 23605324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. E-cadherin, beta-catenin adhesion complex and relation to matrilysin expression in pT3 rectosigmoid cancers.
    Dilek FH; Topak N; Aktepe F; Sahin O; Türel KS; Sahin DA; Dilek ON
    Pathol Res Pract; 2008; 204(11):809-15. PubMed ID: 18674869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
    Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
    Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.
    DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA
    Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma.
    Tucci MG; Lucarini G; Brancorsini D; Zizzi A; Pugnaloni A; Giacchetti A; Ricotti G; Biagini G
    Br J Dermatol; 2007 Dec; 157(6):1212-6. PubMed ID: 17970806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.